![Alexander Pasteur](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexander Pasteur
Direktor/Vorstandsmitglied bei
Owkin, Inc.
Profil
Alexander Thomas Pasteur is currently Director at F-Prime UK Ltd. since 2018, Director at Oviva AG since 2016, Director at Tenpoint Therapeutics Ltd. since 2020, Director at Ciwit BV, Director at NodThera Ltd. since 2018, Director at Owkin, Inc. since 2019, Partner at Impresa Management LLC (United Kingdom) since 2012, and holds a position at F-Prime, Inc. Former roles include Director at Arvelle Therapeutics International GmbH from 2020 to 2021, Independent Non-Executive Director at Orchard Therapeutics Plc in 2018, Non-Executive Director at Acacia Pharma Group Ltd. from 2013 to 2018, Director at Xention Pharma Ltd., Director at Vantia Ltd., Non-Executive Director at Acacia Pharma Ltd., Director at Orchard Therapeutics (Europe) Ltd., Partner at MVM Partners LLP in 2012, Investment Manager at First Cambridge Gateway LP, Manager at Gateway Fund Co. Pte Ltd. from 2001 to 2005, and Consultant at OC&C.
Education includes graduate and doctorate degrees from the University of Cambridge, conferred in 1992 and 1996 respectively.
Aktive Positionen von Alexander Pasteur
| Unternehmen | Position | Beginn |
|---|---|---|
Owkin, Inc.
 Owkin, Inc. Packaged SoftwareTechnology Services Develops AI technology that accelerates drug discovery by combining multimodal patient data and large language models | Direktor/Vorstandsmitglied | 01.03.2019 |
F-Prime UK Ltd.
 F-Prime UK Ltd. Miscellaneous Commercial ServicesCommercial Services Provides strategy development, market research, investment advisory, administration support services | Direktor/Vorstandsmitglied | 29.05.2018 |
Tenpoint Therapeutics Ltd.
 Tenpoint Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotech company developing treatments to rejuvenate vision in the aging eye | Direktor/Vorstandsmitglied | 01.12.2020 |
Ciwit BV
 Ciwit BV Internet Software/ServicesTechnology Services Provides electronic data capture platform for medical research | Direktor/Vorstandsmitglied | - |
NodThera Ltd.
 NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Direktor/Vorstandsmitglied | 01.02.2018 |
Oviva AG
 Oviva AG Medical/Nursing ServicesHealth Services Operates as a virtual clinic for weight-related conditions | Direktor/Vorstandsmitglied | 01.09.2016 |
Impresa Management LLC (United Kingdom)
 Impresa Management LLC (United Kingdom) Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 01.10.2012 |
Ehemalige bekannte Positionen von Alexander Pasteur
| Unternehmen | Position | Ende |
|---|---|---|
Arvelle Therapeutics International GmbH
 Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Develops and commercializes therapeutic for patients suffering from CNC disorders | Direktor/Vorstandsmitglied | 01.01.2021 |
| ORCHARD THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 30.10.2018 |
| ░░░░░░ ░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ ░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Alexander Pasteur
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
93
Beziehungen ersten Grades
19
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 19 |
|---|---|
Xention Pharma Ltd.
 Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and researches drugs | Health Technology |
First Cambridge Gateway LP
 First Cambridge Gateway LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
MVM Partners LLP
 MVM Partners LLP Investment ManagersFinance MVM Partners invests in companies located across the globe. The firm targets companies operating in the fields of healthcare and life sciences sectors. It provides financing for growth capital requirements with an investment size of USD 20 - 100 million. | Finance |
OC&C | |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acacia Pharma Ltd.
 Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Provides supportive care product opportunities for post-surgical and cancer patients | Health Technology |
Vantia Ltd.
 Vantia Ltd. Miscellaneous Commercial ServicesCommercial Services Provides molecule agonists of vasopressin receptors | Commercial Services |
Acacia Pharma Group Ltd.
 Acacia Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company that engages in developing and commercializing novel products for surgery, invasive procedures & chemotherapy | Health Technology |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Health Technology |
Oviva AG
Oviva AG Medical/Nursing ServicesHealth Services Operates as a virtual clinic for weight-related conditions | Health Services |
Owkin, Inc.
Owkin, Inc. Packaged SoftwareTechnology Services Develops AI technology that accelerates drug discovery by combining multimodal patient data and large language models | Technology Services |
Gateway Fund Co. Pte Ltd. | |
Impresa Management LLC (United Kingdom)
Impresa Management LLC (United Kingdom) Investment ManagersFinance Functions as an alternative investment manager | Finance |
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Health Technology |
Ciwit BV
Ciwit BV Internet Software/ServicesTechnology Services Provides electronic data capture platform for medical research | Technology Services |
Orchard Therapeutics Plc
 Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Develops and commercializes therapeutic for patients suffering from CNC disorders | Health Technology |
F-Prime UK Ltd.
F-Prime UK Ltd. Miscellaneous Commercial ServicesCommercial Services Provides strategy development, market research, investment advisory, administration support services | Commercial Services |
Tenpoint Therapeutics Ltd.
Tenpoint Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotech company developing treatments to rejuvenate vision in the aging eye | Health Technology |
